{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:16:32Z","timestamp":1770351392191,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03001-y","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T16:43:14Z","timestamp":1756053794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Female and male hormonal-dependent malignancies: the role of long non-coding RNAs"],"prefix":"10.1007","volume":"42","author":[{"given":"Yahia","family":"Elgharib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Medhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayrouz","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten","family":"Elgharib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekram","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"issue":"3","key":"3001_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3001_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3322\/caac.21225","volume":"64","author":"A Colditz","year":"2014","unstructured":"Colditz A, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186\u201394. https:\/\/doi.org\/10.3322\/caac.21225.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3001_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2023.2261524","volume":"26","author":"X Liu","year":"2023","unstructured":"Liu X, Lin L, Cai Q, et al. Do testosterone and sex hormone-binding globulin affect cancer risk? A Mendelian randomization and bioinformatics study. Aging Male. 2023;26(1): 2261524. https:\/\/doi.org\/10.1080\/13685538.2023.2261524.","journal-title":"Aging Male"},{"issue":"1","key":"3001_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","volume":"19","author":"H Li","year":"2020","unstructured":"Li H, Liu Z, Wu N, et al. PARP inhibitor resistance: the underlying mechanisms and clinical implications. Mol Cancer. 2020;19(1):107. https:\/\/doi.org\/10.1186\/s12943-020-01227-0.","journal-title":"Mol Cancer"},{"issue":"5","key":"3001_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/febs.16395","volume":"289","author":"E Skourti","year":"2022","unstructured":"Skourti E, Dhillon P. Cancer epigenetics: promises and pitfalls for cancertherapy. FEBS J. 2022;289(5):1156\u20139. https:\/\/doi.org\/10.1111\/febs.16395.","journal-title":"FEBS J"},{"issue":"25","key":"3001_CR6","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1200\/JCO.2016.67.1487","volume":"34","author":"H Rugo","year":"2016","unstructured":"Rugo H, Rumble R, Macrae E, et al. Endocrine therapy for hormone receptor-positive metastatic breast cancer: American society of clinical oncology guideline. J Clin Oncol. 2016;34(25):3069\u2013103. https:\/\/doi.org\/10.1200\/JCO.2016.67.1487.","journal-title":"J Clin Oncol"},{"key":"3001_CR7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.37349\/etat.2024.00266","volume":"5","author":"N Thakur","year":"2024","unstructured":"Thakur N, Singh P, Bagri A, et al. Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies. Explor Target Anti-tumor Ther. 2024;5:1110\u201334. https:\/\/doi.org\/10.37349\/etat.2024.00266.","journal-title":"Explor Target Anti-tumor Ther"},{"issue":"2","key":"3001_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C, Chen L, et al. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3001_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.993687","volume":"13","author":"D Kashyap","year":"2023","unstructured":"Kashyap D, Sharma R, Goel N, et al. Coding roles of long non coding RNAs in breast cancer: emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. Front Genet. 2023;13: 993687. https:\/\/doi.org\/10.3389\/fgene.2022.993687.","journal-title":"Front Genet"},{"issue":"1","key":"3001_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"L Siegel","year":"2022","unstructured":"Siegel L, Miller D, Fuchs E, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"3001_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/437971","author":"S Ibrahim","year":"2014","unstructured":"Ibrahim S, Khaled M, Mikhail N, et al. Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014. https:\/\/doi.org\/10.1155\/2014\/437971.","journal-title":"J Cancer Epidemiol"},{"key":"3001_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-019-0703-1","volume":"12","author":"R Malone","year":"2020","unstructured":"Malone R, Oliva M, Sabatini J, et al. Molecular profiling for precision cancer therapies. Genome med. 2020;12:1\u201319. https:\/\/doi.org\/10.1186\/s13073-019-0703-1.","journal-title":"Genome med"},{"issue":"1","key":"3001_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-04664-z","volume":"12","author":"C Cava","year":"2022","unstructured":"Cava C, Armaos A, Lang B, et al. Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes. Sci Rep. 2022;12(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-021-04664-z.","journal-title":"Sci Rep"},{"issue":"19","key":"3001_CR14","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou M, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98(19):10869\u201374. https:\/\/doi.org\/10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3001_CR15","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1038\/s41467-020-19349-w","volume":"11","author":"Q Shi","year":"2020","unstructured":"Shi Q, Li Y, Li S, et al. LncRNA DILA1 inhibits cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020;11(1):5513. https:\/\/doi.org\/10.1038\/s41467-020-19349-w.","journal-title":"Nat Commun"},{"issue":"5","key":"3001_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41388-019-1040-y","volume":"39","author":"H Yousefi","year":"2020","unstructured":"Yousefi H, Maheronnaghsh M, Molaei F, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39(5):953\u201374. https:\/\/doi.org\/10.1038\/s41388-019-1040-y.","journal-title":"Oncogene"},{"key":"3001_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"3001_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/tau.2017.03.06","volume":"6","author":"F Ghiam","year":"2017","unstructured":"Ghiam F, Vesprini D, Liu K. Long noncoding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer. Transl Androl Urol. 2017;6:326\u201330. https:\/\/doi.org\/10.21037\/tau.2017.03.06.","journal-title":"Transl Androl Urol"},{"issue":"3","key":"3001_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4161\/rna.8.3.14800","volume":"8","author":"JM Silva","year":"2011","unstructured":"Silva JM, Boczek NJ, Berres MW. Lsinct5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8(3):496\u2013505. https:\/\/doi.org\/10.4161\/rna.8.3.14800.","journal-title":"RNA Biol"},{"issue":"1","key":"3001_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13058-021-01491-y","volume":"23","author":"S Liu","year":"2021","unstructured":"Liu S, Chen W, Hu H, et al. Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Breast Cancer Res. 2021;23(1):115. https:\/\/doi.org\/10.1186\/s13058-021-01491-y.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"3001_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021145","volume":"24","author":"V Melone","year":"2023","unstructured":"Melone V, Salvati A, Brusco N, et al. Functional relationships between long non-coding RNAs and estrogen receptor alpha: a new frontier in hormone-responsive breast cancer management. Int J Mol Sci. 2023;24(2): 1145. https:\/\/doi.org\/10.3390\/ijms24021145.","journal-title":"Int J Mol Sci"},{"key":"3001_CR22","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1073\/pnas.1507882112","volume":"112","author":"A Salameh","year":"2015","unstructured":"Salameh A, Lee AK, Cardo-Vila M, et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A. 2015;112:8403\u20138. https:\/\/doi.org\/10.1073\/pnas.1507882112.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3001_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/1471-2407-12-507","volume":"12","author":"LB Ferreira","year":"2012","unstructured":"Ferreira LB, Palumbo A, de Mello KD, et al. PCA3 noncoding RNA is involved in the control of prostate cancer cell survival and modulates androgen receptor signaling. BMC Cancer. 2012;12:507. https:\/\/doi.org\/10.1186\/1471-2407-12-507.","journal-title":"BMC Cancer"},{"key":"3001_CR24","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.1007\/s13277-015-3490-3","volume":"36","author":"L Liu","year":"2015","unstructured":"Liu L, Liu Y, Zhuang C, et al. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer. Tumour Biol. 2015;36:7685\u20139. https:\/\/doi.org\/10.1007\/s13277-015-3490-3.","journal-title":"Tumour Biol"},{"key":"3001_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nbt.1914","volume":"29","author":"R Prensner","year":"2011","unstructured":"Prensner R, Iyer K, Balbin A, et al. Sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29:742\u20139. https:\/\/doi.org\/10.1038\/nbt.1914.","journal-title":"Nat Biotechnol"},{"key":"3001_CR26","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.7150\/jca.23685","volume":"9","author":"Q Yuan","year":"2018","unstructured":"Yuan Q, Chu H, Ge Y, et al. LncRNA PCAT1 and its genetic variant rs1902432 are associated with prostate cancer risk. J Cancer. 2018;9:1414\u201320. https:\/\/doi.org\/10.7150\/jca.23685.","journal-title":"J Cancer"},{"key":"3001_CR27","first-page":"366","volume":"9","author":"S Zhang","year":"2017","unstructured":"Zhang S, Dong X, Ji T, et al. Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. Am J Transl Res. 2017;9:366\u201375.","journal-title":"Am J Transl Res."},{"key":"3001_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.omtn.2019.11.021","volume":"19","author":"Y Yu","year":"2020","unstructured":"Yu Y, Gao F, He Q, et al. LncRNA UCA1 functions as a ceRNA to promote prostate cancer progression via sponging miR143. Mol Ther. 2020;19:751\u20138. https:\/\/doi.org\/10.1016\/j.omtn.2019.11.021.","journal-title":"Mol Ther"},{"key":"3001_CR29","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.juro.2014.05.031","volume":"45","author":"R Prensner","year":"2013","unstructured":"Prensner R, Iyer K, Sahu A, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI\/SNF complex. Nat Genet. 2013;45:1392\u20138. https:\/\/doi.org\/10.1016\/j.juro.2014.05.031.","journal-title":"Nat Genet"},{"key":"3001_CR30","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.3892\/mmr.2019.10602","volume":"20","author":"X Dai","year":"2019","unstructured":"Dai X, Liang Z, Liu L, et al. Silencing of MALAT1 inhibits migration and invasion by sponging miR13p in prostate cancer cells. Mol Med Rep. 2019;20:3499\u2013508. https:\/\/doi.org\/10.3892\/mmr.2019.10602.","journal-title":"Mol Med Rep"},{"key":"3001_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109666","volume":"123","author":"T Hao","year":"2020","unstructured":"Hao T, Wang Z, Yang J, et al. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140\/ BIRC6 axis. Biomed Pharmacother. 2020;123: 109666. https:\/\/doi.org\/10.1016\/j.biopha.2019.109666.","journal-title":"Biomed Pharmacother"},{"key":"3001_CR32","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1038\/ncomms6383","volume":"5","author":"D Chakravarty","year":"2014","unstructured":"Chakravarty D, Sboner A, Nair S, et al. The estrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5:5383. https:\/\/doi.org\/10.1038\/ncomms6383.","journal-title":"Nat Commun"},{"key":"3001_CR33","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2147\/CMAR.S189052","volume":"11","author":"J Ji","year":"2019","unstructured":"Ji J, Dai X, Yeung J, et al. The role of long non-coding RNA GAS5 in cancers. Cancer Manag Res. 2019;11:2729\u201337. https:\/\/doi.org\/10.2147\/CMAR.S189052.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"3001_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/onc.2008.373","volume":"28","author":"M Mourtada-Maarabouni","year":"2009","unstructured":"Mourtada-Maarabouni M, Pickard R, Hedge L, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28(2):195\u2013208. https:\/\/doi.org\/10.1038\/onc.2008.373.","journal-title":"Oncogene"},{"key":"3001_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154850","volume":"251","author":"MS Hussain","year":"2023","unstructured":"Hussain MS, Majami AA, Ali H, et al. The complex role of MEG3: an emerging long non coding RNA in breast cancer. Pathol Res Pract. 2023;251: 154850. https:\/\/doi.org\/10.1016\/j.prp.2023.154850.","journal-title":"Pathol Res Pract"},{"issue":"21","key":"3001_CR36","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1080\/15384101.2022.2094662","volume":"21","author":"T Pan","year":"2022","unstructured":"Pan T, Ding H, Jin L, et al. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway. Cell Cycle. 2022;21(21):2323\u201337. https:\/\/doi.org\/10.1080\/15384101.2022.2094662.","journal-title":"Cell Cycle"},{"key":"3001_CR37","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.bbadis.2013.05.005","volume":"1832","author":"R Pickard","year":"2013","unstructured":"Pickard R, Mourtada-Maarabouni M, Williams GT. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta. 2013;1832:1613\u201323. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.005.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3001_CR38","first-page":"170","volume":"10","author":"C An","year":"2022","unstructured":"An C, Wang I, Li X, et al. Long non-coding RNA in prostate cancer. Am J Clin Exp Urol. 2022;10(3):170\u20139.","journal-title":"Am J Clin Exp Urol"},{"key":"3001_CR39","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1159\/000438577","volume":"37","author":"G Luo","year":"2015","unstructured":"Luo G, Wang M, Wu X, et al. Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cell Physiol Biochem. 2015;37:2209\u201320. https:\/\/doi.org\/10.1159\/000438577.","journal-title":"Cell Physiol Biochem"},{"key":"3001_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jcmm.13658","volume":"201923","author":"M Wu","year":"2019","unstructured":"Wu M, Huang Y, Chen T, et al. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9- 5p\/QKI-5 axis. J Cell Mol Med. 2019;201923:29\u201338. https:\/\/doi.org\/10.1111\/jcmm.13658.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3001_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/jb\/mvz097","volume":"167","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yang H, Xia W. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2. J Biochemi. 2020;167(3):295\u2013301. https:\/\/doi.org\/10.1093\/jb\/mvz097.","journal-title":"J Biochemi"},{"issue":"10","key":"3001_CR42","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/cells11101679","volume":"11","author":"V Maldonado","year":"2022","unstructured":"Maldonado V, Melendez-Zajgla J. The role of hypoxia-associated long non- coding RNAs in breast cancer. Cells. 2022;11(10):1679. https:\/\/doi.org\/10.3390\/cells11101679.","journal-title":"Cells"},{"issue":"24","key":"3001_CR43","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/s41388-021-01845-y","volume":"40","author":"Y Qiao","year":"2021","unstructured":"Qiao Y, Jin T, Guan S. Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1. Oncogene. 2021;40(24):4198\u2013213. https:\/\/doi.org\/10.1038\/s41388-021-01845-y.","journal-title":"Oncogene"},{"issue":"12","key":"3001_CR44","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.18632\/aging.204824","volume":"15","author":"Z Nie","year":"2023","unstructured":"Nie Z, Xu M, Zhou L, et al. lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level. Aging. 2023;15(12):5734. https:\/\/doi.org\/10.18632\/aging.204824.","journal-title":"Aging"},{"issue":"1","key":"3001_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.17219\/acem\/152705","volume":"32","author":"W Yang","year":"2023","unstructured":"Yang W, Yang X, Li Q, et al. Long stress induced non-coding transcript 5: a promising therapeutic target for cancer treatment. Adv Clin Exp Med. 2023;32(1):97\u2013106. https:\/\/doi.org\/10.17219\/acem\/152705.","journal-title":"Adv Clin Exp Med"},{"key":"3001_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41416-020-01091-1","volume":"124","author":"T Li","year":"2021","unstructured":"Li T, Liu N, Gao Y, et al. Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepacam. Br J Cancer. 2021;124:247\u201358. https:\/\/doi.org\/10.1038\/s41416-020-01091-1.","journal-title":"Br J Cancer"},{"key":"3001_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","volume":"13","author":"A Zhang","year":"2015","unstructured":"Zhang A, Zhao C, Kim J, et al. LncRNA HOTAIR enhances the androgen-receptor \u2013 mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 2015;13:209\u201321. https:\/\/doi.org\/10.1016\/j.celrep.2015.08.069.","journal-title":"Cell Rep"},{"issue":"2","key":"3001_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020633","volume":"11","author":"A Al-Shehri","year":"2023","unstructured":"Al-Shehri A, Bakhashab S. Oncogenic long noncoding RNAs in prostate cancer, osteosarcoma, and metastasis. Biomedicines. 2023;11(2): 633. https:\/\/doi.org\/10.3390\/biomedicines11020633.","journal-title":"Biomedicines"},{"issue":"13","key":"3001_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136810","volume":"22","author":"E Filippova","year":"2021","unstructured":"Filippova E, Fridman M, Burdennyy A, et al. Long noncoding RNA GAS5 in breast cancer: epigenetic mechanisms and biological functions. Int J Mol Sci. 2021;22(13): 6810. https:\/\/doi.org\/10.3390\/ijms22136810.","journal-title":"Int J Mol Sci"},{"key":"3001_CR50","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.26355\/eurrev_201908_18737","volume":"23","author":"Y Yang","year":"2019","unstructured":"Yang Y, Xun N, Wu G. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p. Eur Rev Med Pharmacol Sci. 2019;23:6971\u201382. https:\/\/doi.org\/10.26355\/eurrev_201908_18737.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3001_CR51","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.ygeno.2021.04.015","volume":"113","author":"S Dong","year":"2021","unstructured":"Dong S, Ma M, Li M, et al. LncRNA MEG3 regulates breast cancer proliferation and Apoptosis through miR-141\u20133p\/RBMS3axis. Genomics. 2021;113:1689\u2013704. https:\/\/doi.org\/10.1016\/j.ygeno.2021.04.015.","journal-title":"Genomics"},{"issue":"6","key":"3001_CR52","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1002\/jcb.27851","volume":"120","author":"H Jiang","year":"2019","unstructured":"Jiang H, Xiong W, Chen L, et al. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt\/\u03b2-catenin pathway in prostate cancer. J Cell Biochem. 2019;120(6):8965\u201374. https:\/\/doi.org\/10.1002\/jcb.27851.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3001_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2023.2276384","volume":"18","author":"W Kim","year":"2023","unstructured":"Kim W, Baek M, Jung S, et al. Elovl2-as1 suppresses tamoxifen resistance by sponging mir-1233-3p in breast cancer. Epigenetics. 2023;18(1): 2276384. https:\/\/doi.org\/10.1080\/15592294.2023.2276384.","journal-title":"Epigenetics"},{"issue":"1","key":"3001_CR54","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1038\/s41467-022-34702-x","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Luo R, Zhang Y, et al. Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer. Nat Commun. 2022;13(1):7160. https:\/\/doi.org\/10.1038\/s41467-022-34702-x.","journal-title":"Nat Commun"},{"issue":"9","key":"3001_CR55","first-page":"873","volume":"39","author":"W Lin","year":"2023","unstructured":"Lin W, Mo Q, Kong J, et al. FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p. J Med Sci. 2023;39(9):873\u201382.","journal-title":"J Med Sci"},{"issue":"40","key":"3001_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi3821","volume":"9","author":"Z Cai","year":"2023","unstructured":"Cai Z, Shi Q, Li Y, et al. Lncrna EILA promotes CDK4\/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein. Sci Adv. 2023;9(40): eadi3821. https:\/\/doi.org\/10.1126\/sciadv.adi3821.","journal-title":"Sci Adv"},{"issue":"2","key":"3001_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/boc.201800054","volume":"111","author":"J He","year":"2019","unstructured":"He J, Sun M, Geng H, et al. Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p. Biol Cell. 2019;111(2):39\u201350. https:\/\/doi.org\/10.1111\/boc.201800054.","journal-title":"Biol Cell"},{"key":"3001_CR58","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/15384047.2020.1727700","volume":"21","author":"X Li","year":"2020","unstructured":"Li X, Han X, Wei P, et al. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Cancer Biol Ther. 2020;21:452\u201362. https:\/\/doi.org\/10.1080\/15384047.2020.1727700.","journal-title":"Cancer Biol Ther"},{"key":"3001_CR59","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.2147\/OTT.S197009","volume":"12","author":"Y Ma","year":"2019","unstructured":"Ma Y, Fan B, Ren Z, et al. Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p\/JAG1 pathway. Onco Targets Ther. 2019;12:5485\u201397. https:\/\/doi.org\/10.2147\/OTT.S197009.","journal-title":"Onco Targets Ther"},{"key":"3001_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109422","volume":"65","author":"X Jiang","year":"2020","unstructured":"Jiang X, Guo S, Zhang Y, et al. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p. Cell Signal. 2020;65: 109422. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109422.","journal-title":"Cell Signal"},{"key":"3001_CR61","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103917","volume":"12","author":"C Lin","year":"2020","unstructured":"Lin C, Chou F, Lu J, et al. Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-na\u00efve prostate cancer cells. Aging. 2020;12: 7. https:\/\/doi.org\/10.18632\/aging.103917.","journal-title":"Aging"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03001-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:16:07Z","timestamp":1758093367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03001-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03001-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is a narrative review based on previously published literature and does not involve any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All of the authors have consented to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All of the authors have consented to the publication of the text.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"444"}}